Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rambus Inc. Common Stock (RMBS) vs Teladoc Health Inc (TDOC) Price & Performance

Rambus Inc. Common StockTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Rambus Inc. Common Stock vs Teladoc Health Inc — how do they compare? Rambus Inc. Common Stock trades at $89.45 (market cap $10.66B), while Teladoc Health Inc trades at $5.79 (market cap $1.09B). The key difference: Rambus Inc. Common Stock is far larger — about 9.8× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Rambus Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rambus Inc. Common Stock for 0 Days and Teladoc Health Inc for 39 Days on average.

RMBSTDOC
Market Cap
$10.66B$1.09B
Volume
2,136,0754,279,268
Sector
TechnologyHealth
52-Week High
$170.66$9.72
52-Week Low
$79.73$4.47
Typical Hold Time
0 Days39 Days
Enterprise Value
$9.85B$1.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rambus Inc. Common Stock

Rambus (RMBS) trades at $98.17, down 2.84% over 24 hours, with a neutral technical signal and key support at $96. The company reported strong profitability with a 31.69% net income margin and beat EPS estimates in two of the last three quarters. Recent news highlights its focus on AI infrastructure with new product launches, positioning it to benefit from growing demand for high-speed memory solutions.

The outlook is positive given analyst consensus of a $161.75 price target and 78.57% buy ratings, but risks include high valuation multiples and competitive pressures. Execution on AI-driven growth and maintaining earnings momentum are critical for stock appreciation, while any miss in upcoming results could pressure the premium valuation.

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.81, down 1.86% on the day, with a bearish technical signal and mixed quarterly earnings performance. The company maintains strong gross margins at 68.97% but continues to report net losses, with a -7.13% net income margin for 2025. Recent developments include new executive appointments and ongoing legal investigations, while analyst consensus shows 35.71% buy ratings with a $8.83 price target.

TDOC presents a turnaround opportunity with attractive valuation metrics (P/S 0.43, EV/EBITDA 6.28) and positive cash flow from operations, but faces significant execution risks from persistent losses, BetterHelp segment challenges, and legal scrutiny. The stock trades near multi-year lows, offering potential upside if management can stabilize the business and return to profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RMBS
100% Buy0% Sell
Avg holding period · 0 Days
TDOC
12% Buy88% Sell
Avg holding period · 39 Days

Top news

Latest headlines on both assets

About Rambus Inc. Common Stock

Rambus Inc. is a semiconductor and silicon IP company that licenses chip interface and security technologies, including memory interface chipsets for DDR5 and DDR4 server and client DIMMs, interface IP for PCIe, CXL, and HBM, and security IP such as Root of Trust and memory encryption. It serves data center, AI, automotive, and IoT markets.

Read more on RMBS →

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →